J. Forbes

FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke

Martin Dennis, Steven Lewis, Gina Cranswick et al. · Health Technology Assessment · 2006 · 162 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +5

BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer

B. J. Thurlimann, Aparna Keshaviah, H.T. Mouridsen et al. · Journal of Clinical Oncology · 2005 · 120 citations

Medicine, Endocrinology, Endocrine Oncology +1

BCIRG 007: First overall survival analysis of randomized phase III trial of trastuzumab plus docetaxel with or without carboplatin as first line therapy in HER2 amplified metastatic breast cancer (MBC)

Mark D. Pegram, J. Forbes, Tadeusz Pieńkowski et al. · Journal of Clinical Oncology · 2007 · 46 citations

Medicine, Oncology, Pharmacology +17

BCIRG 007: Randomized phase III trial of trastuzumab plus docetaxel with or without carboplatin first line in HER2 positive metastatic breast cancer (MBC)

J. Forbes, Tadeusz Pieńkowski, Vicente Valero et al. · Journal of Clinical Oncology · 2006 · 33 citations

Medicine, Oncology, Pharmacology +17

ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies

Richard S. Finn, Judy Dering, Charles Ginther et al. · Journal of Clinical Oncology · 2006 · 15 citations

Medicine, Oncology, Pharmacotherapy +17